Great West Life Assurance Co. Can Has $3.74 Million Stake in Merit Medical Systems, Inc. (MMSI)

Great West Life Assurance Co. Can raised its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,549 shares of the medical instruments supplier’s stock after buying an additional 5,038 shares during the quarter. Great West Life Assurance Co. Can owned about 0.13% of Merit Medical Systems worth $3,735,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Benjamin F. Edwards & Company Inc. acquired a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $36,000. Financial Gravity Companies Inc. acquired a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $43,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Merit Medical Systems by 8.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,802 shares of the medical instruments supplier’s stock valued at $212,000 after purchasing an additional 303 shares during the period. D.A. Davidson & CO. acquired a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $227,000. Finally, NEXT Financial Group Inc acquired a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $229,000. Institutional investors own 96.46% of the company’s stock.

In other news, CFO Raul Jr. Parra sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $60.20, for a total transaction of $301,000.00. Following the sale, the chief financial officer now owns 1,000 shares in the company, valued at approximately $60,200. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Michael E. Stillabower sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $58.05, for a total value of $580,500.00. Following the sale, the director now owns 63,618 shares in the company, valued at approximately $3,693,024.90. The disclosure for this sale can be found here. In the last quarter, insiders have sold 35,000 shares of company stock worth $2,090,300. Company insiders own 5.16% of the company’s stock.

Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Merit Medical Systems from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research report on Thursday, January 3rd. BidaskClub cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, February 27th. Finally, Needham & Company LLC restated a “buy” rating and issued a $73.00 target price on shares of Merit Medical Systems in a research note on Monday, December 17th. One analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $67.60.

NASDAQ MMSI opened at $60.19 on Tuesday. The company has a market capitalization of $3.34 billion, a price-to-earnings ratio of 35.62, a PEG ratio of 2.50 and a beta of 1.10. The company has a current ratio of 2.45, a quick ratio of 1.32 and a debt-to-equity ratio of 0.40. Merit Medical Systems, Inc. has a 52 week low of $43.05 and a 52 week high of $66.34.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Tuesday, February 26th. The medical instruments supplier reported $0.48 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.45 by $0.03. Merit Medical Systems had a return on equity of 11.26% and a net margin of 4.76%. The firm had revenue of $232.25 million for the quarter, compared to analysts’ expectations of $231.03 million. During the same quarter in the previous year, the business posted $0.33 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts expect that Merit Medical Systems, Inc. will post 2.01 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by WKRB News and is the sole property of of WKRB News. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.wkrb13.com/2019/03/19/great-west-life-assurance-co-can-has-3-74-million-stake-in-merit-medical-systems-inc-mmsi.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Further Reading: What is an Initial Public Offering (IPO)?

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.